Related Experiment Video
Updated: Feb 5, 2026

Labeling Stem Cells with Ferumoxytol, an FDA-Approved Iron Oxide Nanoparticle
Published on: November 4, 2011
Comparison of Approved Dosages for Pediatric and Adult Populations Based on US Labeling Information
Keizo Hanada1, Masayuki Kaneko1, Mamoru Narukawa1
11 Graduate School of Pharmaceutical Sciences, Department of Clinical Medicine (Pharmaceutical Medicine), Kitasato University, Tokyo, Japan.
Insights
Pediatric drug dosages based on body weight (BW) were higher than adult doses, while body surface area (BSA) dosages were similar. Age proximity strongly correlates relative pediatric drug dosages.
Area of Science:
- Pharmacology
- Pediatric Medicine
- Drug Development
Background:
- Recent legislation in the US and EU mandates pediatric drug dosage approvals.
- This necessitates understanding factors influencing pediatric dose selection.
Purpose of the Study:
- To identify key factors in selecting appropriate drug dosages for pediatric populations.
- To analyze the relationship between pediatric and adult drug dosages based on different metrics.
Main Methods:
- Utilized the FDA's New Pediatric Labeling Information Database.
- Standardized drug labels for pediatric age groups (6 months, 2, 6, 11 years) by age, body weight (BW), and body surface area (BSA).
- Calculated pediatric-to-adult dosage ratios for 108 drugs.
Main Results:
- Pediatric dosages normalized by BW exceeded adult dosages (ratios > 1).
- Pediatric dosages normalized by BSA were comparable to adult dosages (ratios ≈ 1).
- Relative dosages at 6 months showed a stronger correlation with 2-year-olds' dosages than with other age groups.
Conclusions:
- Approved pediatric drug dosages based on BW are higher than adult dosages.
- Approved pediatric drug dosages based on BSA are similar to adult dosages.
- Closer age groups exhibit stronger correlations in relative drug dosages.
Background:
The passing of legislation in the United States and the European Union has led to the approval of dosages for pediatric use. This study was conducted in an attempt to find potentially important factors with regard to dose selection for the pediatric population.
Methods:
The FDA's New Pediatric Labeling Information Database was used for this study. Drug labels for patients aged 6 months as well as those for patients aged 2, 6, and 11 years were standardized based on dosages expressed by age, normalized body weight (BW), and body surface area (BSA) in order to obtain ratios of pediatric-to-adult dosages. Labeling for 108 drugs were extracted for the analysis.
Results:
Ratios of pediatric-to-adult dosages based on BW were higher than 1, but those based on BSA were around 1. Relative dosages at 6 months of age showed a stronger correlation with those at 2 years compared to those at other ages.
Conclusion:
The approved dosages for pediatrics based on BW were higher than those of adults, but the ones based on BSA were almost the same as those of adults. The closer the age groups, the stronger the correlation of relative dosages between the groups.
More Related Videos
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
09:24Immunohistochemistry and Multiple Labeling with Antibodies from the Same Host Species to Study Adult Hippocampal Neurogenesis
Published on: April 22, 2015
Related Concept Videos
FDA Approved Drugs: Changes to Approved Drugs
Dosage Regimen: Multiple Oral Dosage
Dosage Compensation
In addition to sexual development, the X chromosome has genes involved in autosomal functions such as brain development and the immune system. Therefore, males and females with distinct numbers of X chromosomes will...
The Sense of Self: Reflected Self-Appraisal and Social Comparison
Dosage Regimen: Individualization
Conservation of Small Populations